ID
33378
Description
Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains the Pharmacogenetic (PGx) research form. It has to be filled in if a PGx was done during study.
Lien
https://clinicaltrials.gov/ct2/show/NCT00599612
Mots-clés
Versions (2)
- 04/12/2018 04/12/2018 -
- 07/12/2018 07/12/2018 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
7 décembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Safety, tolerability, excretion balance and pharmacokinetics of Losmapimod in healthy males, NCT00599612
Pharmacogenetic (PGx) research
- StudyEvent: ODM
Description
Consent for pharmacogenetic (PGx) research (DNA)
Alias
- UMLS CUI-1
- C0021430
- UMLS CUI-2
- C2347500
Description
Informed consent for PGx
Type de données
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C2347500
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0009797
Description
No informed consent, reason
Type de données
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C0566251
Description
Other reason for none informed consent
Type de données
text
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C1272696
- UMLS CUI [1,3]
- C0205394
- UMLS CUI [1,4]
- C0566251
Description
Blood sample collection
Alias
- UMLS CUI-1
- C0005834
Description
Blood sample collection for PGx
Type de données
text
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C0031325
Description
day month year
Type de données
date
Alias
- UMLS CUI [1,1]
- C0005834
- UMLS CUI [1,2]
- C0031325
- UMLS CUI [1,3]
- C0011008
Description
Withdrawl of consent
Alias
- UMLS CUI-1
- C1707492
Description
Withdrawn consent for PGx
Type de données
text
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0031325
Description
Date of informed consent withdraw
Type de données
date
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0031325
- UMLS CUI [1,3]
- C0011008
Description
Blood sample destruction
Alias
- UMLS CUI-1
- C1948029
- UMLS CUI-2
- C0178913
Description
Request for blood sample destruction
Type de données
text
Alias
- UMLS CUI [1,1]
- C1948029
- UMLS CUI [1,2]
- C0178913
- UMLS CUI [1,3]
- C1272683
Description
Reason for request
Type de données
text
Alias
- UMLS CUI [1,1]
- C0566251
- UMLS CUI [1,2]
- C1272683
Description
Other reason for request
Type de données
text
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C0566251
- UMLS CUI [1,3]
- C1272683
Similar models
Pharmacogenetic (PGx) research
- StudyEvent: ODM
C2347500 (UMLS CUI-2)
C2347500 (UMLS CUI [1,2])
C0009797 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1272696 (UMLS CUI [1,2])
C0205394 (UMLS CUI [1,3])
C0566251 (UMLS CUI [1,4])
C0031325 (UMLS CUI [1,2])
C0031325 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0031325 (UMLS CUI [1,2])
C0031325 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
C0178913 (UMLS CUI-2)
C0178913 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])
C1272683 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,2])
C1272683 (UMLS CUI [1,3])